key: cord-0940919-xej56nom authors: Ng, Khuen Foong; Kothari, Trishul; Bandi, Srini; Bird, Paul William; Goyal, Kanika; Zoha, Mohammad; Rai, Vinayak; Tang, Julian Wei‐Tze title: COVID‐19 multisystem inflammatory syndrome in three teenagers with confirmed SARS‐CoV‐2 infection date: 2020-07-06 journal: J Med Virol DOI: 10.1002/jmv.26206 sha: ac92bec7b8f0df2ea422b39fcdcf1a99cee9c3ad doc_id: 940919 cord_uid: xej56nom Coronavirus disease 2019 (COVID‐19) is generally a relatively mild illness in children. An emerging disease entity coined as pediatric inflammatory multisystem syndrome temporally associated with SARS‐CoV‐2 (PIMS‐TS) has been reported recently, but is very rare and only affects a very small minority of children. Here we describe the clinical presentations and outcomes of three teenagers with serologically‐confirmed SARS‐CoV‐2 infection admitted to a pediatric intensive care unit for PIMS‐TS. Although their initial presentations were very similar, their COVID‐19‐related disease varied in severity. There was no obvious cardiomegaly in the second CXR of Case 3. All three cases required respiratory support, one was placed on Although our patients had some signs and symptoms compatible with KD, for example, fever, rash, mucous membrane changes, conjunctivitis, cervical lymphadenopathy, thrombocytosis (in the later stage of disease), myocarditis, and coronary artery dilatation, there were differences from classical KD, such as being in an older age group, respiratory and gastrointestinal involvement, marked lymphopenia, thrombocytopenia and more severe clinical course. 4, 5, 11, 12 KD is a type of vasculitis of unknown etiology which occurs more commonly in younger children. 16 KD is essentially a clinical diagnosis (characterized by fever, rash, non-purulent conjunctivitis, cervical lymphadenopathy, oral and extremities changes) and there is no diagnostic test currently. 16 It can also present atypically in the form of KD shock syndrome (KDSS) and rarely macrophage activation syndrome (MAS), mimicking PIMS-TS. 16 It is postulated that KD may be a manifestation of a genetic predisposition towards an abnormal immune response to some specific infectious agents. 16 MAS is closely related to hemophagocytic lymphohistiocytosis MAS complicating KD is also commoner in older age groups and it can result in multiorgan dysfunction. 18 and pericardial effusion (40-50%). 4, 5, 11, 12 The striking similarities between KDSS and PIMS-TS may suggest that they are actually one entity instead of two different conditions. An alternative hypothesis on the mechanism of PIMS-TS is the de- Children presenting with PIMS-TS require prompt and aggressive respiratory, antibiotic, vasopressin, and fluid therapy. They should be discussed early with specialists of appropriate expertize and experience for escalation of care and for the use of IVIG with or without anti-inflammatory agents (corticosteroid, tocilizumab) and heparin. 7, 9 Further research into the optimum management of this condition is ongoing. 7 However, it must be emphasized that in the vast majority of cases, COVID-19 is a relatively mild illness in children. Cases of PIMS-TS are very rare and will only affect a very small minority of children. This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. World Health Organization. WHO coronavirus disease (COVID-19) dashboard Coronavirus (COVID-19) in the UK. https:// coronavirus.data.gov.uk/. Updated 2020 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review Hyperinflammatory shock in children during COVID-19 pandemic An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study New York City Health Department. 2020 health alert #13: pediatric multi-system inflammatory syndrome potentially associated with COVID-19 Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19 Kawasaki-like disease: emerging complication during the COVID-19 pandemic Rapid risk assessment: paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children Multisystem inflammatory syndrome in children and adolescents with COVID-19 Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York city Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans Association between a novel human coronavirus and Kawasaki disease Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association Macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management Kawasaki disease complicated with macrophage activation syndrome: a systematic review Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-gamma as biomarkers for early recognition Clinical manifestations of Kawasaki disease shock syndrome Describing Kawasaki shock syndrome: results from a retrospective study and literature review How to cite this article COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection The authors declare that there are no conflict of interests.